Skip to main content
John Gallagher, MD, Vascular Surgery, West Islip, NY

JohnFGallagherMD

Vascular Surgery • West Islip, NY

Physician

Join to view full profile

Dr. Gallagher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gallagher's full profile

Already have an account?

  • Office

    580 Union Blvd
    West Islip, NY 11795
    Phone+1 631-321-6801
    Fax+1 631-321-3869

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1974 - 1980
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1974

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1981 - Present
  • NY State Medical License
    NY State Medical License 1975 - 2025
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Press Mentions

  • Compartmentalizing and Coping: Life as an Emergency Doctor During COVID
    Compartmentalizing and Coping: Life as an Emergency Doctor During COVIDAugust 5th, 2021
  • Cryoballoon Pulmonary Vein Isolation as a Standard Approach for Interventional Treatment of Atrial Fibrillation. A Review and a Practical Guide to an Effective and Safe Procedure
    Cryoballoon Pulmonary Vein Isolation as a Standard Approach for Interventional Treatment of Atrial Fibrillation. A Review and a Practical Guide to an Effective and Safe ProcedureDecember 29th, 2020
  • Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation with Active Ankylosing Spondylitis: Four-Year Results from a Phase 3 Study, MEASURE 1
    Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation with Active Ankylosing Spondylitis: Four-Year Results from a Phase 3 Study, MEASURE 1October 27th, 2020

Professional Memberships

Dr. John Gallagher, Dr. John Gallagher, MD, Dr. J Gallagher, Dr. John F Gallagher